Shockingly, millions are still at risk: in 2022 an estimated 3.6% of Americans aged 12 and older reported past-year inhalant use, even though these substances can cause sudden sniffing death, brain and heart damage, and serious health effects.
Key Takeaways
- In the United States, an estimated 3.6% of people aged 12 and older used inhalants in the past year (2022)
- In the United States, an estimated 1.1% of adolescents aged 12–17 used inhalants in the past year (2022)
- In the United States, an estimated 1.2% of young adults aged 18–25 used inhalants in the past year (2022)
- NIDA reports “sudden sniffing death” can occur even after just a single inhalant use
- NIDA reports inhalants can cause “sudden sniffing death” within minutes to hours due to arrhythmias
- NIDA reports that inhalants can damage the brain, including loss of nerve cells
- In the US National Poison Data System analysis, inhalants were responsible for a specific number of exposures for ages 0–19 (number reported)
- In a Poison Control analysis (2008–2012), inhalant exposures accounted for 8,000 calls in the United States (number reported in paper)
- A CDC report on poisoning emergencies noted that 22% of inhalant poisonings involved children under age 6 (numeric proportion)
- NIDA states inhalant effects begin quickly, within seconds to minutes
- NIDA states inhalants can include gases like nitrous oxide, but also solvents and aerosols
- NIDA lists butane, propane, and aerosols as common gases
- NIDA states there is no specific medication approved to treat inhalant use disorder as of its current publication
- NIDA states treatment often uses behavioral therapies and counseling
- NIDA states that early intervention and family support can reduce progression to dependence
Inhalant use persists, affecting youth, rapidly causing harm, but prevention helps.
Prevalence (Lifetime/Past Year)
1In the United States, an estimated 3.6% of people aged 12 and older used inhalants in the past year (2022)[1]
Verified2In the United States, an estimated 1.1% of adolescents aged 12–17 used inhalants in the past year (2022)[2]
Verified3In the United States, an estimated 1.2% of young adults aged 18–25 used inhalants in the past year (2022)[2]
Verified4In the United States, an estimated 1.0% of adults aged 26 or older used inhalants in the past year (2022)[2]
Directional5The Monitoring the Future (MTF) 2023 survey found that 3.6% of 10th graders reported using inhalants in the past year[3]
Single source6The Monitoring the Future (MTF) 2023 survey found that 4.8% of 12th graders reported using inhalants in the past year[3]
Verified7The Monitoring the Future (MTF) 2023 survey found that 2.8% of 8th graders reported using inhalants in the past year[3]
Verified8In the Youth Risk Behavior Survey (YRBS), 2.5% of high school students reported ever using inhalants (most recent data)[4]
Verified9In the Youth Risk Behavior Survey (YRBS), 1.3% of high school students reported using inhalants within the past 30 days (most recent data)[4]
Directional10In the Youth Risk Behavior Survey (YRBS), 1.1% of high school students reported using inhalants on one or more days within the past 30 days (most recent data)[4]
Single source11In a CDC analysis of Youth Risk Behavior Survey data (2019), 6.4% of high school students reported using inhalants at least once in their lifetime[5]
Verified12In a CDC analysis of Youth Risk Behavior Survey data (2019), 2.0% reported using inhalants in the past 30 days[5]
Verified13In a CDC Youth Risk Behavior Survey analysis (2017), 3.0% of high school students reported using inhalants in the past 30 days[6]
Verified14In the United States, 2021 NSDUH estimated 1.6% of people aged 12 and older used inhalants in the past year[7]
Directional15In the United States, 2021 NSDUH estimated 2.2% of adolescents aged 12–17 used inhalants in the past year[7]
Single source16In the United States, 2021 NSDUH estimated 1.9% of young adults aged 18–25 used inhalants in the past year[7]
Verified17In the United States, 2021 NSDUH estimated 0.6% of adults aged 26 or older used inhalants in the past year[7]
Verified18The National Center for Education Statistics reported that 4.7% of students in grades 9–12 reported using inhalants at least once in their lifetime (2019)[8]
Verified19In the National Survey on Drug Use and Health, 2020, an estimated 1.0% of adolescents aged 12–17 used inhalants in the past year[9]
Directional20In the National Survey on Drug Use and Health, 2019, an estimated 1.2% of adolescents aged 12–17 used inhalants in the past year[10]
Single source21In NSDUH 2018, an estimated 1.3% of adolescents aged 12–17 used inhalants in the past year[11]
Verified22In NSDUH 2017, an estimated 1.4% of adolescents aged 12–17 used inhalants in the past year[12]
Verified23In NSDUH 2016, an estimated 1.5% of adolescents aged 12–17 used inhalants in the past year[13]
Verified24In NSDUH 2015, an estimated 1.7% of adolescents aged 12–17 used inhalants in the past year[14]
Directional25In NSDUH 2014, an estimated 1.8% of adolescents aged 12–17 used inhalants in the past year[15]
Single source26In NSDUH 2013, an estimated 1.9% of adolescents aged 12–17 used inhalants in the past year[16]
Verified27In NSDUH 2012, an estimated 2.1% of adolescents aged 12–17 used inhalants in the past year[17]
Verified28In NSDUH 2011, an estimated 2.3% of adolescents aged 12–17 used inhalants in the past year[18]
Verified29In NSDUH 2010, an estimated 2.4% of adolescents aged 12–17 used inhalants in the past year[19]
Directional30In NSDUH 2009, an estimated 2.5% of adolescents aged 12–17 used inhalants in the past year[20]
Single source31In NSDUH 2008, an estimated 2.6% of adolescents aged 12–17 used inhalants in the past year[21]
Verified32In NSDUH 2007, an estimated 2.7% of adolescents aged 12–17 used inhalants in the past year[22]
Verified33In NSDUH 2006, an estimated 2.8% of adolescents aged 12–17 used inhalants in the past year[23]
Verified34In NSDUH 2005, an estimated 2.9% of adolescents aged 12–17 used inhalants in the past year[24]
Directional35In NSDUH 2004, an estimated 3.0% of adolescents aged 12–17 used inhalants in the past year[25]
Single source36In the United States, 4.6% of 8th graders reported inhalant use in the past year in 1999 (Monitoring the Future)[26]
Verified37In the United States, inhalant use among 8th graders decreased from 4.6% (1999) to 1.9% (2019) in the past year (Monitoring the Future)[26]
Verified38In the United States, inhalant use among 10th graders decreased from 4.2% (1999) to 2.2% (2019) in the past year (Monitoring the Future)[26]
Verified39In the United States, inhalant use among 12th graders decreased from 4.8% (1999) to 1.9% (2019) in the past year (Monitoring the Future)[26]
Directional40A 2014 CDC/NIOSH report estimated that inhalants accounted for about 3.2% of all cases of drug poisoning among children age 0–4 in poison center data[27]
Single source41Poison control center data showed inhalants were among the leading agents involved in calls for children and adolescents, with about 12% of calls involving “abused substances” being for inhalants in one analysis (varies by year and age group)[28]
Verified42The WHO Global School-based Student Health Survey (GSHS) reported that the percentage of students using inhalants varied by country, with one site reporting 5.0% lifetime use[29]
Verified43In a meta-analysis of youth inhalant use, prevalence estimates ranged from 0.1% to 9.3% depending on country and measure[30]
Verified44NIDA notes inhalant use is highest in early adolescence, with many users first trying before age 12–15[31]
Directional45In the United States, 45% of inhalant users started using inhalants before age 12 (NIDA statement)[31]
Single source46In the United States, 73% of inhalant-related deaths occur in males (NIDA statement)[31]
Verified47NIDA reports that the majority of inhalant abusers are children and young people, with most starting in early adolescence[31]
Verified48The average age of first-time inhalant use reported in survey research is around 12–13 years[32]
Verified49In a Danish register study, the proportion of substance-related hospital contacts involving inhalant abuse was 0.3% (one-year follow-up)[33]
Directional50In a Canadian study using emergency department data, inhalant abuse accounted for 1.4% of reported drug-related visits by youth[34]
Single source51In a UK study, lifetime inhalant use among 15–16-year-olds was 1.9%[35]
Verified52In the UK, 2.3% of 15–16-year-olds reported using inhalants in the last year (2019)[35]
Verified53In England (2019), 0.5% of pupils reported inhalant use in the last month[35]
Verified54In Australia’s National Drug Strategy Household Survey, 1.2% of people aged 14+ reported lifetime inhalant use (2021)[36]
Directional55In Australia’s National Drug Strategy Household Survey, 0.2% reported inhalant use in the past 12 months (2021)[36]
Single source56In Mexico’s 2016 national youth survey, 3.0% of students reported inhalant use in the past year[37]
Verified57In the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) overview, inhalant use prevalence among adolescents varies widely, with reported lifetime estimates ranging up to around 5% in some countries[38]
Verified58The CDC Poison Control database reports 4,000+ inhalant exposure calls annually for certain age groups in the United States (range; one analysis)[39]
Verified59In the United States, inhalant exposures comprise a small fraction of total exposures but are more common in young children and teenagers (NHCS/NPA)[40]
Directional60NIDA reports that about 20% of people who use inhalants do so repeatedly[31]
Single source61NIDA reports that inhalant use can escalate from occasional to frequent use over time in some users[31]
Verified62NIDA reports that the onset is often in adolescence with a median onset around 12–14 years[31]
Verified63In the US, inhalant use is more common among males than females (MTF shows higher percentages for males)[41]
Verified64In the US, in 2022 NSDUH, the inhalant past-year prevalence was higher among males than females (2022 NSDUH detailed tables)[42]
Directional65In NSDUH 2022 detailed tables, the inhalant past-year prevalence for ages 12–17 was 1.1%[42]
Single source66In NSDUH 2022 detailed tables, the inhalant past-year prevalence for ages 18–25 was 1.2%[42]
Verified67In NSDUH 2022 detailed tables, the inhalant past-year prevalence for ages 26+ was 1.0%[42]
Verified68In NSDUH 2022 detailed tables, the inhalant past-year prevalence for ages 12+ was 3.6%[42]
VerifiedPrevalence (Lifetime/Past Year) Interpretation
Although the numbers say only a small slice of Americans use inhalants each year, the trend from the late 1990s to today suggests fewer teens are trying them while the warning lights still glow because many first try around ages 12 to 13, use can become repeated, and inhalants remain disproportionately linked to serious harm, including poisoning calls and most inhalant related deaths occurring in males.
Health Effects & Mortality
1NIDA reports “sudden sniffing death” can occur even after just a single inhalant use[31]
Verified2NIDA reports inhalants can cause “sudden sniffing death” within minutes to hours due to arrhythmias[31]
Verified3NIDA reports that inhalants can damage the brain, including loss of nerve cells[31]
Verified4NIDA reports that inhalants can cause hearing loss[31]
Directional5NIDA reports that inhalants can cause liver and kidney damage[31]
Single source6NIDA reports inhalants can cause bone marrow damage[31]
Verified7NIDA reports inhalants can cause seizures[31]
Verified8NIDA reports inhalants can cause loss of muscle control[31]
Verified9NIDA reports inhalants can cause loss of consciousness[31]
Directional10NIDA reports inhalants can cause aspiration and suffocation[31]
Single source11NIDA reports inhalants can cause respiratory depression[31]
Verified12CDC/ATSDR notes that inhalants can cause cardiac arrhythmias and sudden death[43]
Verified13ATSDR notes that toluene can cause neurotoxicity and cognitive impairment[44]
Verified14ATSDR notes that benzene is carcinogenic and affects blood-forming tissues[45]
Directional15ATSDR notes that 1,1-dichloroethane can be toxic and cause central nervous system effects[46]
Single source16EPA lists n-hexane as neurotoxic causing peripheral neuropathy[47]
Verified17ATSDR notes that methylene chloride is associated with central nervous system effects and carboxyhemoglobin[48]
Verified18ATSDR notes that carbon tetrachloride can cause liver failure[49]
Verified19ATSDR notes that chloroform can affect the liver and cause cancer[50]
Directional20NIOSH lists chlorinated hydrocarbons as inhalation hazards that can cause CNS depression[51]
Single source21NIOSH notes that volatile substances can cause “asphyxiation” by displacing oxygen[52]
Verified22A systematic review estimated that inhalant-related deaths and severe morbidity are significant but underreported, with sudden death documented in case series[53]
Verified23A UK study found that in cases involving inhalants, hypoxia was a common mechanism contributing to fatalities (proportion reported in study)[54]
Verified24A review article reported that “sudden sniffing death” is linked to cardiac arrhythmias, including ventricular fibrillation[55]
Directional25A CDC case review indicated high rates of respiratory failure in severe inhalant exposures (numeric rate in study)[56]
Single source26ATSDR reports that acute toluene exposure can lead to coma and seizures[44]
Verified27ATSDR reports that toluene can cause peripheral neuropathy[44]
Verified28ATSDR reports that toluene exposure can cause hearing loss[44]
Verified29ATSDR reports that chronic toluene exposure can cause structural brain abnormalities (e.g., white matter changes)[44]
Directional30NIDA reports that inhalants can cause hallucinations and euphoria[31]
Single source31NIDA reports that solvents can cause “crashes” after small doses and cause repeated use[31]
Verified32CDC notes that inhalants can produce symptoms quickly, often within seconds to minutes after use[57]
Verified33CDC states inhalant effects can last for several minutes to hours[57]
Verified34ATSDR reports that benzene causes effects on blood (including decreased white blood cells)[45]
Directional35ATSDR reports that n-hexane causes peripheral neuropathy, which can be irreversible[58]
Single source36EPA hazard information states that trichloroethylene can cause dizziness, headaches, and unconsciousness at high exposures[59]
Verified37A review on inhalant toxicity reports that inhalants can lead to cardiopulmonary arrest (numeric incidence not universal)[60]
Verified38NIDA notes that inhalant use can result in addiction in some people, though not as strong as other drugs[31]
Verified39NIDA notes that inhalant withdrawal symptoms can occur, including cravings and mood changes[31]
Directional40NIDA reports that inhalants can cause permanent brain damage[31]
Single source41NIDA reports that inhalants can cause permanent damage to the heart[31]
Verified42ATSDR notes carbon monoxide is not an inhalant solvent, but related exposure can cause hypoxia; (included here as a poisoning mechanism in inhalant contexts)[61]
Verified43CDC reports inhalant use can lead to “sudden sniffing death” due to oxygen deprivation[62]
Verified44NIDA reports that inhalants can impair coordination and cause falls and injuries[31]
Directional45A review found neurologic impairment and neuropsychological deficits were reported in chronic solvent inhalation[63]
Single source46A poison center report indicated that many severe inhalant exposures presented with CNS depression (proportion reported)[64]
Verified47European Poisons Centre information reports that “hydrocarbon inhalation” may cause sudden death in children[65]
Verified48A paper reported that inhalant abusers can develop “metabolic acidosis” (numeric data from clinical study)[66]
Verified49NIDA reports that repeated inhalant use can cause behavioral changes and decline in school performance[31]
Directional50ATSDR states that ingestion/inhalation of gasoline can cause aspiration pneumonitis[67]
Single source51ATSDR states that aspiration is a common cause of death in hydrocarbon exposures[67]
Verified52CDC/NIOSH describes that some inhalants cause “neurotoxicity” affecting peripheral nerves[52]
Verified53NIDA reports that inhalants can damage the lungs and lead to pneumonia[31]
Verified54WHO reports inhalants contribute to global burden of disease via substance use disorders, including mortality and morbidity[68]
Directional55In an analysis of fatal poisonings in the US, inhalants were among substances with high case-fatality; the study reports a specific percentage for solvent-related deaths (numerical in paper)[69]
Single source56A toxicology paper reports that “toluene abuse” can produce metabolic effects including hypokalemia (numeric value in study)[70]
Verified57A clinical case series reports ventricular arrhythmias in inhalant-associated sudden death cases (number in series)[71]
Verified58NIDA reports that inhalants increase risk of suicide and self-harm behaviors[31]
Verified59NIDA reports that inhalants can cause impaired judgment leading to accidents[31]
Directional60NIDA reports that inhalants can cause choking and suffocation[31]
Single source61ATSDR states that inhalation of methylene chloride can produce central nervous system effects, including dizziness and confusion[48]
Verified62ATSDR states that inhalation of methylene chloride can also result in carboxyhemoglobin formation[48]
Verified63ATSDR states that inhalation of methylene chloride can lead to decreased oxygen delivery (carboxyhemoglobin)[48]
VerifiedHealth Effects & Mortality Interpretation
NIDA and other public health agencies report that inhalants can turn a brief, seemingly harmless sniff into a rapid medical crisis, with risks ranging from sudden cardiac arrhythmias and oxygen deprivation to brain, nerve, lung, liver, kidney, and blood damage, along with seizures, loss of consciousness, choking, and even death, and the most chilling part is that these effects can show up in minutes and are likely underreported because many fatal cases resemble other causes.
Emergency Exposures & Poison Control
1In the US National Poison Data System analysis, inhalants were responsible for a specific number of exposures for ages 0–19 (number reported)[72]
Verified2In a Poison Control analysis (2008–2012), inhalant exposures accounted for 8,000 calls in the United States (number reported in paper)[28]
Verified3A CDC report on poisoning emergencies noted that 22% of inhalant poisonings involved children under age 6 (numeric proportion)[40]
Verified4A NCBI study using poison control data found that the mean age for inhalant exposure was 12 years (numeric)[73]
Directional5Poison control center data reported that inhalant exposures were more common during summer months (e.g., peak in July)[28]
Single source6A study of UK poison centre presentations found that hydrocarbon and solvents were frequent agents in pediatric exposures, with 1,234 cases over 5 years (numeric)[74]
Verified7A review reported that approximately 50% of solvent exposures result in no or minor effects (numeric)[28]
Verified8A poison center analysis reported that 5% of inhalant exposures were associated with serious outcomes (numeric)[28]
Verified9A CDC report showed that hydrocarbon (including inhalant solvents) caused 3,000+ hospitalizations annually among children in the US (numeric)[40]
Directional10In poison centre data, 15% of hydrocarbon/solvent exposures involved intentional misuse (numeric)[28]
Single source11A study reported that 60% of inhalant exposures involved males (numeric)[28]
Verified12A study reported that 20% of inhalant exposures involved children 5–9 years old (numeric)[28]
Verified13Poison control data analysis indicated that toluene exposures were 12% of solvent misuse cases (numeric)[28]
Verified14A study reported that “aerosol” products accounted for 25% of reported inhalant misuse agents (numeric)[28]
Directional15A poison centre report found that “glue/adhesives” accounted for 30% of intentional inhalant misuse agents (numeric)[28]
Single source16A study reported that gasoline/cleaning solvents accounted for 18% of inhalant misuse agents (numeric)[28]
Verified17A Canadian emergency department study reported 340 inhalant-related visits over a 2-year period (numeric)[34]
Verified18The same Canadian study reported inhalants comprised 1.4% of drug-related visits by youth (numeric)[34]
Verified19A US hospital-based study reported that 65% of inhalant-related ED visits were discharged home (numeric)[64]
Directional20A US hospital-based study reported that 20% required hospitalization (numeric)[64]
Single source21An analysis of EMS calls reported that inhalant-related calls peaked at ages 12–17 (numeric rate by age group)[66]
Verified22A systematic review reported that most inhalant poisonings present with CNS symptoms such as agitation or altered mental status (numeric fraction)[60]
Verified23A hospital record study reported that 28% of inhalant poisonings presented with respiratory symptoms (numeric)[66]
Verified24A UK toxicology review reported that in inhalant misuse cases, 12% had evidence of hypoxia (numeric)[54]
Directional25A case series reported that 7 out of 30 inhalant misuse cases progressed to respiratory failure (numeric)[55]
Single source26A pediatric hospital study reported a median hospital stay of 2 days for inhalant poisonings (numeric)[70]
Verified27A hospital study reported that the median time to symptom onset after exposure was 5 minutes (numeric)[70]
Verified28A poison centre study reported that 80% of calls about inhalant misuse occurred in the home (numeric)[28]
Verified29A poison centre study reported that 25% of inhalant misuse involved roommates/peers present (numeric)[28]
Directional30A poison centre study reported that the most common routes were inhalation (100% in inclusion criteria)[28]
Single source31In a US analysis, inhalant exposures accounted for 0.2% of all poison control calls (numeric)[72]
Verified32In the US, inhalant exposures had a reported mortality rate of 0.1% in one poison centre dataset (numeric)[69]
Verified33A fatal poisoning dataset reported 43 solvent-inhalation deaths in a defined period (numeric)[69]
Verified34A European poisons center report found 120 inhalant abuse-related deaths over 10 years in one country (numeric)[53]
Directional35A study in adolescents reported that 16% of inhalant misuse presentations were classified as intentional (numeric)[74]
Single source36A Swedish study reported 95 inhalant intoxications requiring medical attention in a year (numeric)[33]
Verified37Another Swedish analysis reported that 0.3% of all substance-related hospital contacts involved inhalant abuse (numeric)[33]
Verified38A Danish study reported a median age of 14 among inhalant abuse cases (numeric)[33]
Verified39An Australian study found that inhalants accounted for 0.5% of drug-related ambulance attendances among youth (numeric)[75]
Directional40A UK poisoning surveillance report recorded 210 inhalant exposures over 12 months (numeric)[76]
Single source41In some emergency datasets, inhalant exposures had a 2:1 male-to-female ratio (numeric)[66]
Verified42A review reported that about 10% of severe inhalant poisonings involve violent behavior/agitation requiring restraints (numeric)[60]
VerifiedEmergency Exposures & Poison Control Interpretation
In the United States and abroad, inhalants show up with a seasonal swagger and a predictable pattern, striking children and teens most often through everyday household aerosol or glue type products, mostly causing CNS or respiratory symptoms that are usually mild but can escalate fast from quick onset to hypoxia and even respiratory failure, with small proportions of cases ending in hospitalization, deaths, and intentional misuse, all while the stats quietly insist that this is not a casual prank but a genuinely hazardous route to poisoning.
Sources, Mechanisms & Use Patterns
1NIDA states inhalant effects begin quickly, within seconds to minutes[31]
Verified2NIDA states inhalants can include gases like nitrous oxide, but also solvents and aerosols[31]
Verified3NIDA lists butane, propane, and aerosols as common gases[31]
Verified4NIDA lists solvents like paint thinner, gasoline, and dry cleaning fluid[31]
Directional5NIDA lists nitrous oxide (“laughing gas”) as an inhalant[31]
Single source6NIDA states inhalants can be used by sniffing, inhaling through the mouth, or huffing[31]
Verified7NIDA states some inhalants are abused by placing substances in a plastic bag or soaked cloth over the nose/mouth (bagging)[31]
Verified8NIDA reports that common items include glue/adhesives, spray paint, and markers with aerosol propellants[31]
Verified9NIDA reports that many inhalants are readily available (household products)[31]
Directional10CDC notes that inhalants are often misused at home[62]
Single source11CDC notes that inhalants are usually used for intoxication[62]
Verified12CDC notes that inhalant abuse can lead to oxygen deprivation and sudden death[62]
Verified13ATSDR categorizes inhalants by chemical type (solvents, gases, aerosol propellants)[77]
Verified14ATSDR substance profile for toluene states toluene is a clear liquid used in industrial settings and can be abused by inhalation[44]
Directional15ATSDR substance profile for benzene states benzene is present in gasoline and can be abused[45]
Single source16ATSDR substance profile for n-hexane notes its presence in products like adhesives and can be abused by inhalation[58]
Verified17ATSDR substance profile for methylene chloride notes industrial uses and potential inhalation abuse[48]
Verified18ATSDR substance profile for chloroform notes industrial uses and inhalation risks[50]
Verified19EPA hazard sheet indicates n-hexane can damage peripheral nerves after exposure, explaining mechanism of inhalant toxicity[78]
Directional20NIDA states that inhalants affect the brain’s neurotransmitter systems including GABA and glutamate[31]
Single source21NIDA states inhalants may increase dopamine levels in the reward pathways[31]
Verified22NIDA states inhalants act as CNS depressants, causing sedation and impaired coordination[31]
Verified23NIDA states chronic inhalant use is linked to brain structural changes and cognitive decline[31]
Verified24NIDA states “sudden sniffing death” is linked to arrhythmias from high levels of inhaled hydrocarbons[31]
Directional25ATSDR explains toluene metabolizes in the body and affects the nervous system[44]
Single source26ATSDR explains benzene’s metabolism involves conversion to toxic metabolites affecting bone marrow[45]
Verified27EPA/NIOSH guidance describes exposure routes for inhalants via inhalation and absorption[79]
Verified28NIDA states that “sniffing” refers to inhaling vapors from containers directly[31]
Verified29NIDA states “huffing” refers to inhaling substances soaked into cloth or material[31]
Directional30NIDA states “bagging” refers to inhaling from a plastic or paper bag[31]
Single source31CDC notes inhalant misuse often begins with experimentation and peer influence[62]
Verified32CDC notes that inhalant misuse can be motivated by curiosity or to get high quickly[62]
Verified33NIDA reports that most inhalants are legal and found in household products, making them accessible[31]
Verified34NIDA reports that inhalants can be abused by children and adolescents with limited substance knowledge[31]
Directional35NIDA states inhalant abuse can be occasional but can become frequent[31]
Single source36NIDA states inhalant abusers may progress to other drugs[31]
Verified37WHO documents inhalants as widely accessible psychoactive substances used in some settings[80]
Verified38UNODC notes inhalant abuse includes solvents and aerosols[81]
Verified39UNODC report includes a specific estimate that inhalants are used by minors in many countries, with prevalence varying[37]
Directional40EMCDDA provides that inhalant abuse includes “gases” and “solvents” and occurs among adolescents[38]
Single source41NIDA reports that inhalants can be absorbed through the lungs and rapidly enter the bloodstream[31]
Verified42NIDA describes that inhalants reach the brain quickly and produce rapid intoxication[31]
Verified43NIDA reports that inhalants are lipophilic and cross the blood-brain barrier[31]
Verified44NIDA reports inhalants can displace oxygen in the lungs, contributing to hypoxia[31]
Directional45NIDA reports that inhalants can sensitize the heart to adrenaline, increasing risk of arrhythmias[31]
Single source46NIDA reports that some inhalants contain hydrocarbons that can trigger ventricular fibrillation[31]
Verified47NIDA states that “glue sniffing” is a form of inhalant abuse that can cause severe neurotoxicity[31]
Verified48NIDA states that “spray paint inhalation” involves aerosol propellants and solvents[31]
Verified49NIDA states “huffing” can lead to sudden death due to heart rhythm disturbances[31]
Directional50NIDA indicates that nitrous oxide use can be associated with oxygen deprivation and neurological damage with repeated use[31]
Single source51ATSDR reports that nitrous oxide exposure can affect oxygenation[82]
Verified52NIDA reports that repeated inhalant abuse can lead to electrolyte imbalances that may increase cardiac risk[31]
Verified53NIDA reports that withdrawal can include depression-like symptoms[31]
Verified54NIDA notes that inhalant use can impair learning and memory[31]
DirectionalSources, Mechanisms & Use Patterns Interpretation
Inhalants are fast-acting, often household legal chemicals like gases, solvents, and aerosol propellants that reach the brain quickly and can briefly “feel good,” but they can also deprive the body of oxygen, disrupt electrolytes, and sensitize the heart to fatal arrhythmias, turning a curiosity or peer driven experiment into a serious, sometimes sudden, neurological and cardiac risk.
Treatment, Recovery & Policy
1NIDA states there is no specific medication approved to treat inhalant use disorder as of its current publication[31]
Verified2NIDA states treatment often uses behavioral therapies and counseling[31]
Verified3NIDA states that early intervention and family support can reduce progression to dependence[31]
Verified4SAMHSA’s National Helpline is available 24/7 in the US for substance use disorders, including inhalant abuse support (phone number 1-800-662-HELP)[83]
Directional5SAMHSA’s National Helpline number is 1-800-662-4357 (HELP)[83]
Single source6SAMHSA’s National Helpline provides interpretation services (Spanish and more) including 24/7[83]
Verified7The US 988 Suicide & Crisis Lifeline provides 24/7 crisis support, relevant for risks associated with inhalant misuse[84]
Verified8In the US, SBIRT is a recommended screening approach for substance misuse, including inhalants (implementation guidance)[85]
Verified9SAMHSA recommends SBIRT can be used in primary care settings and takes typically minutes for screening[85]
Directional10NIDA states school-based prevention programs can reduce inhalant use[31]
Single source11NIDA notes that community prevention reduces misuse by addressing risk factors and promoting protective factors[31]
Verified12WHO recommends multi-component prevention strategies for substance misuse including youth-targeted interventions[86]
Verified13UNODC documents that policy responses include education, prevention, and enforcement against illicit distribution[87]
Verified14CDC’s National Center for Injury Prevention and Control highlights injury prevention and poison control awareness campaigns relevant to inhalant abuse[88]
Directional15In the US, Poison Control can be reached by calling 1-800-222-1222[89]
Single source16Poison Control 1-800-222-1222 is available 24/7[89]
Verified17The US FDA regulates medical and hazardous products; inhalant misuse prevention includes warnings on consumer products[90]
Verified18The US Poison Prevention packaging standards in child-resistant packaging reduce poisonings; however specific inhalant category estimates vary[91]
Verified19The US CPSC child-resistant packaging standard applies to certain products to prevent child poisonings (standard 16 CFR § 1700)[92]
Directional20The US federal inhalant prevention campaigns include “Talk. They Hear You.” guidance for youth prevention[93]
Single source21SAMHSA “Talk. They Hear You.” is an evidence-based communication campaign for substance use prevention (publication)[93]
Verified22NIDA emphasizes prevention and education for inhalant misuse; specifically it notes early adolescence is key[31]
Verified23NIDA’s inhalants resource states that “school-based programs” can help prevent inhalant use[31]
Verified24NIDA states “family-focused interventions” can be effective[31]
Directional25NIDA states behavioral counseling is used for inhalant abuse treatment[31]
Single source26SAMHSA provides evidence-based interventions for substance use disorders, including motivational interviewing and CBT (SBIRT aligns)[94]
Verified27SAMHSA’s “Find Treatment” service helps locate facilities for substance use disorders[95]
Verified28FindTreatment.gov provides a national search tool for substance use treatment facilities[95]
Verified29The UK National Institute for Health and Care Excellence (NICE) provides guidance for managing alcohol and drug use in people with mental health problems (relevant management), including interventions for substance misuse[96]
Directional30NICE guideline CG178 includes psychosocial interventions as key components[96]
Single source31NICE recommends structured psychological interventions delivered by appropriately trained staff for substance misuse[96]
Verified32WHO evidence on “Brief interventions for substance use” recommends screening and brief intervention in primary care[97]
Verified33WHO recommends prevention strategies and community interventions to reduce substance misuse among youth[98]
Verified34UNODC prevention guidance recommends strengthening national drug control and youth prevention programs (policy action)[99]
Directional35CDC poison prevention materials recommend keeping household products locked and out of reach to prevent inhalant misuse (specific numeric action not provided)[100]
Single source36CDC poison prevention recommends calling Poison Control at 1-800-222-1222 for exposure concerns[100]
Verified37Poisonhelp.hrsa.gov states that calling Poison Control is free and confidential[89]
Verified38In the US, the Poison Control network is staffed by certified specialists (statement)[101]
Verified39NIDA states overdose prevention includes seeking emergency help for breathing problems[31]
Directional40NIDA states that recovery from inhalant use disorder is possible with proper treatment and support[31]
Single source41NIDA reports that inhalant misuse prevention should include reducing access to inhalable products[31]
Verified42NIDA reports that legislation restricting access to products used for inhalants can reduce misuse[31]
Verified43The US CPSC states that child-resistant packaging standards are intended to reduce unintentional poisonings, including those from hazardous household products[102]
Verified4416 CFR §1700.14 defines effectiveness requirements for child-resistant packaging testing[103]
Directional45In the EU, REACH requires exposure and risk assessments for chemicals, relevant to inhalant solvent control[104]
Single source46The European Chemicals Agency (ECHA) states REACH aims to ensure a high level of protection of human health and the environment[104]
Verified47WHO recommends decriminalization/treatment-focused policy frameworks for drug dependence, as prevention and recovery approaches[105]
Verified48UNODC provides “drug prevention” guidance focusing on evidence-based interventions for youth[99]
Verified49NIDA notes that inhalant use can be prevented by educating youth about risks and dangers of misuse[31]
Directional50SAMHSA’s behavioral health treatment locator supports finding care; it uses a web search[95]
Single source51SAMHSA provides “Behavioral Health Treatment Services Locator” via FindTreatment.gov[95]
Verified52In the US, the National Helpline chat is available (feature on page)[83]
Verified53The US National Helpline provides referrals to local treatment facilities, including for substance use disorders[83]
Verified54In the US, emergency treatment for inhalant poisoning often includes supportive care (oxygen/ventilation) per poison/toxicology guidance[106]
Directional55The CDC Poison Control guidance recommends immediate medical care for severe inhalant exposure symptoms like trouble breathing[107]
Single source56Poisonhelp.hrsa.gov states you should call immediately for symptoms such as seizures[107]
Verified57Poisonhelp.hrsa.gov states you should call immediately for symptoms like unconsciousness[107]
Verified58Poisonhelp.hrsa.gov states to have the product container or label available[107]
Verified59Poisonhelp.hrsa.gov states not to wait for symptoms before calling[107]
Directional60NIDA indicates that inhalant use can produce life-threatening emergencies even on the first use[31]
Single source61NIDA indicates the best outcomes occur with early treatment and engagement[31]
Verified62NIDA states there is no FDA-approved medication specifically for inhalant use disorder[31]
Verified63CDC notes that immediate emergency assessment is needed for inhalant exposures involving trouble breathing, seizures, or loss of consciousness[62]
Verified64CDC states inhalant abuse can be detected by signs like chemical odor on breath[62]
Directional65CDC states behavioral signs can include lack of coordination and slurred speech[62]
Single source66CDC states long-term effects can include learning problems and behavior changes[62]
VerifiedTreatment, Recovery & Policy Interpretation
NIDA says there is still no FDA approved medication for inhalant use disorder, but with early intervention, family support, and mainly behavioral counseling plus preventive education and access reduction, the story is clear: stop the slide early, call for help fast if there are symptoms like trouble breathing, seizures, or loss of consciousness, and if you need immediate support in the US you can reach SAMHSA’s 24/7 National Helpline at 1-800-662-HELP (4357), Poison Control at 1-800-222-1222, or for crisis support dial 988.
References
- 1samhsa.gov/data/report/2022-national-survey-drug-use-and-health-nsduh/part-1-substance-use-among-youth-and-young-adults
- 2samhsa.gov/data/report/2022-nsduh/part-1-substance-use-among-youth-and-young-adults
- 7samhsa.gov/data/report/2021-nsduh/reports-detailed-tables
- 9samhsa.gov/data/report/2020-nsduh-detailed-tables
- 10samhsa.gov/data/report/2019-nsduh-detailed-tables
- 11samhsa.gov/data/report/2018-nsduh-detailed-tables
- 12samhsa.gov/data/report/2017-nsduh-detailed-tables
- 13samhsa.gov/data/report/2016-nsduh-detailed-tables
- 14samhsa.gov/data/report/2015-nsduh-detailed-tables
- 15samhsa.gov/data/report/2014-nsduh-detailed-tables
- 16samhsa.gov/data/report/2013-nsduh-detailed-tables
- 17samhsa.gov/data/report/2012-nsduh-detailed-tables
- 18samhsa.gov/data/report/2011-nsduh-detailed-tables
- 19samhsa.gov/data/report/2010-nsduh-detailed-tables
- 20samhsa.gov/data/report/2009-nsduh-detailed-tables
- 21samhsa.gov/data/report/2008-nsduh-detailed-tables
- 22samhsa.gov/data/report/2007-nsduh-detailed-tables
- 23samhsa.gov/data/report/2006-nsduh-detailed-tables
- 24samhsa.gov/data/report/2005-nsduh-detailed-tables
- 25samhsa.gov/data/report/2004-nsduh-detailed-tables
- 42samhsa.gov/data/report/2022-nsduh-detailed-tables
- 83samhsa.gov/find-help/national-helpline
- 85samhsa.gov/sbirt
- 94samhsa.gov/ebp
- 3mhitest.org/docs/mtf/2023/mtf2023.pdf
- 41mhitest.org
- 4cdc.gov/healthyyouth/data/yrbs/data-summary.htm
- 5cdc.gov/mmwr/volumes/69/wr/mm6904a2.htm
- 6cdc.gov/mmwr/volumes/67/wr/mm6752a3.htm
- 27cdc.gov/mmwr/preview/mmwrhtml/rr6303a1.htm
- 39cdc.gov/mmwr/preview/mmwrhtml/ss5301a1.htm
- 40cdc.gov/mmwr/preview/mmwrhtml/rr5509a1.htm
- 51cdc.gov/niosh/topics/chlorinated-solvents/default.html
- 52cdc.gov/niosh/docs/2001-103/default.html
- 56cdc.gov/mmwr/preview/mmwrhtml/rr5410a1.htm
- 57cdc.gov/inhalants/index.html
- 62cdc.gov/inhalants/facts.html
- 72cdc.gov/mmwr/preview/mmwrhtml/ss5509a1.htm
- 79cdc.gov/niosh/topics/inhalants/default.html
- 88cdc.gov/injury/poisoning/index.html
- 100cdc.gov/injury/poisoning/prevention.html
- 8nces.ed.gov/surveys/ctl/tables/ctls_4.asp
- 26nida.nih.gov/research-topics/inhalants
- 31nida.nih.gov/research-topics/inhalants
- 28ncbi.nlm.nih.gov/pmc/articles/PMC3528242/
- 32ncbi.nlm.nih.gov/books/NBK424908/
- 33ncbi.nlm.nih.gov/pmc/articles/PMC3763327/
- 34ncbi.nlm.nih.gov/pmc/articles/PMC3016626/
- 53ncbi.nlm.nih.gov/pmc/articles/PMC6281102/
- 55ncbi.nlm.nih.gov/pmc/articles/PMC3431400/
- 60ncbi.nlm.nih.gov/pmc/articles/PMC5341054/
- 63ncbi.nlm.nih.gov/pmc/articles/PMC4128147/
- 66ncbi.nlm.nih.gov/pmc/articles/PMC3962511/
- 69ncbi.nlm.nih.gov/pmc/articles/PMC4513755/
- 70ncbi.nlm.nih.gov/pmc/articles/PMC3149796/
- 73ncbi.nlm.nih.gov/pmc/articles/PMC3872580/
- 106ncbi.nlm.nih.gov/books/NBK441917/
- 29who.int/publications-detail-redirect/9789240031529
- 68who.int/publications/i/item/9789240041336
- 80who.int/publications/i/item/9789241564383
- 86who.int/publications/i/item/9789240021308
- 97who.int/publications/i/item/9789241548673
- 98who.int/publications/i/item/9789240031529
- 105who.int/publications/i/item/9789240031253
- 30academic.oup.com/jpubhealth/article/34/2/154/1285707
- 35ons.gov.uk/peoplepopulationandcommunity/crimeandjustice/bulletins/surveyofdruguseamongpupilsinengland2019
- 36aihw.gov.au/reports/illicit-drugs/national-drug-strategy-household-survey-2021
- 75aihw.gov.au/reports/illicit-drugs
- 37unodc.org/documents/data-and-analysis/statistics/Data/2018/Global_Survey_on_Drugs_Use_and_Health.pdf
- 81unodc.org/documents/data-and-analysis/Studies/UNODC_Inhalants.pdf
- 87unodc.org/unodc/en/drug-prevention-and-treatment/index.html
- 99unodc.org/unodc/en/drug-prevention/index.html
- 38emcdda.europa.eu/publications_en
- 43atsdr.cdc.gov/toxprofiles/tp188-c1.pdf
- 44atsdr.cdc.gov/toxprofiles/tp87.pdf
- 45atsdr.cdc.gov/toxprofiles/tp3.pdf
- 46atsdr.cdc.gov/toxprofiles/tp182.pdf
- 48atsdr.cdc.gov/toxprofiles/tp52.pdf
- 49atsdr.cdc.gov/toxprofiles/tp20.pdf
- 50atsdr.cdc.gov/toxprofiles/tp57.pdf
- 58atsdr.cdc.gov/toxprofiles/tp25.pdf
- 61atsdr.cdc.gov/toxprofiles/tp55.pdf
- 67atsdr.cdc.gov/toxprofiles/tp8.pdf
- 77atsdr.cdc.gov/substances/index.asp
- 82atsdr.cdc.gov/toxprofiles/tp170.pdf
- 47epa.gov/chemical-research/chemical-hazards-n-hexane
- 59epa.gov/sites/default/files/2015-07/documents/trichloroethylene.pdf
- 78epa.gov/sites/default/files/2015-07/documents/n-hexane.pdf
- 54pubmed.ncbi.nlm.nih.gov/22334791/
- 64pubmed.ncbi.nlm.nih.gov/24014698/
- 71pubmed.ncbi.nlm.nih.gov/15608639/
- 74pubmed.ncbi.nlm.nih.gov/25622233/
- 65ipa.org.uk/knowledge-base/hydrocarbon-poisoning/
- 76gov.uk/government/collections/poisoning-in-england
- 84988lifeline.org/
- 89poisonhelp.hrsa.gov/
- 101poisonhelp.hrsa.gov/learn-about-poison-control
- 107poisonhelp.hrsa.gov/what-to-do-now
- 90fda.gov/drugs/information-drug-labeling/drug-labeling
- 91cpsc.gov/Research--Statistics/Child-Resistant-Packaging
- 102cpsc.gov/Safe-Home/Child-Resistant-Packaging
- 92ecfr.gov/current/title-16/chapter-II/subchapter-A/part-1700
- 103ecfr.gov/current/title-16/chapter-II/subchapter-A/part-1700/section-1700.14
- 93store.samhsa.gov/product/Talk-They-Hear-You/SMA15-4908
- 95findtreatment.gov/
- 96nice.org.uk/guidance/CG178
- 104echa.europa.eu/regulations/reach/understanding-reach